Relationship between plasma leptin, insulin and tumor necrosis factor alpha in obese children

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 3, 2005, Pages 275-284

  Aycan, Zehra ^a,c   Berberoǧlu, Merih ^a   Ocal, Gönül ^a   Evliyaoglu, Olcay ^a   Adiyaman, Pelin ^a   Deda, Gülhis ^a   Caksen, Hüseyin ^a   Akar, Nejat ^a   Karahan, Ceren ^a   Cinas, Peyami ^b   Bideci, Aysun ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Insulin; Leptin; Obesity; Tumor necrosis factor alpha

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREPUBERTY; PROTEIN BLOOD LEVEL; PUBERTY; RANK SUM TEST; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

EID: 20144384102     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.3.275     Document Type: Article

References (47)

1. Frederich RC, Hamann A, Anderson S, Loliman B, Lowell BB, Flier JS. Leptin reflects body lipid content in mice: evidence for diet-induced leptin resistance. Nature Med 1995; 1: 1311-1314.
2. Spiegelman BM, Flier JS. Adipogenesis and obesity. Rounding out the big picture. Cell 1996; 87: 377-389.
3. Rink TJ. In search of a satiety factor. Nature 1995; 372: 406-407.
4. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
5. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-548.
6. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Robinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
7. Pelleymounter NM, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
8. Weigle DS, Bukowski TR, Foster DJ, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96: 2065-2070.
9. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 1994; 94: 1543-1549.
10. Toomey D, Redmond P, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995; 76: 2418-2426.
11. Staal van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995; 13: 2600-2605.
12. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996; 271: 665-668.
13. Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes 1998; 47: 515-522.
14. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997; 82: 4080-4082.
15. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. Arch Pediatr Adolesc Med 1995; 149: 1085-1091.
16. Brown K, Luddington R, Baglin T. A common polymorphism in the tumor necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thromboembolism. Br J Haematol 1998; 101: 480-482.
17. Tritos NA, Mantzoros CS. Syndromes of severe insulin resistance. J Clin Endocrinol Metab 1998; 83: 3025-3030.
18. Haffner SM, Gonzalez C, Miettinen H, Kennedy E, Stern MP. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138-1141.
19. Cianfarani S, Geremia C, Germani D, Scire G, Maiorana A, Boemi S. Insulin resistance and insulin-like growth factors in children with intrauterine growth retardation. Is catch-up growth a risk factor? Horm Res 2001; 55: 7-10.
20. Tanner JM. Growth and maturation during adolescence. Nutr Rev 1981; 39: 43-55.
21. Lahlou N, Landais P, De Boissieu D, Bougnères PF. Circulating leptin in normal children and during the dynamic phase of juvenile obesity. Relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism. Diabetes 1997; 46: 989-993.
22. Arslanian S, Suprasongsin C, Kalhan SC, Drash AL, Brna R, Janosky JE. Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure. Metabolism 1998; 47: 309-312.
23. Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D. Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects. Int J Obes 1999; 23: 355-360.
24. Adami GF, Campostano A, Ravera G, Cella F, Ligas B. Relationship between body mass index and serum leptin concentration. Diab Nutr Metab 1998; 11: 17-19.
25. Potau N, Ibanez L, Rique S, Carrascosa A. Pubertal changes in insulin secretion and peripheral insulin sensitivity. Horm Res 1997; 48: 219-226.
26. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997; 82: 1066-1070.
27. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
28. Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, Jardel C, Donner M, Meyer L, Moulin P, Hainque B, Riou JP, Laville M, Koivisto VA, Vidal H. Subcutaneous adipose tissue expression of tumor necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. Eur J Clin Invest 2000; 30: 302-310.
29. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, Goldfine ID, Trischitta V. Increased adipose tissue PC-1 protein content, but not tumor necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 1997; 40: 282-289.
30. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
31. Bulló M, García-Lorda P, Peinado-Onsurbe J, Hernández M, Del Castillo D, Argilés JM, Salas-Salvadó J. TNF-α expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes 2002; 26: 652-658.
32. Berberoǧlu M. Evaluation of the correlation between serum tumor necrosis factor-α and relative body mass index (RBMI) in childhood. J Pediatr Endocrinol Metab 2001; 14: 543-547.
33. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cell. J Biol Chem 1992; 267: 12736-12741.
34. Socher SH, Friedman A, Martinez D. Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J Exp Med 1988; 167: 1957-1962.
35. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-991.
36. Haffner SM, Miettinen H, Mykkänen L, Karhapää P, Rainwater DL, Laasko M. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes 1997; 21: 393-399.
37. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes 2000; 24: S23-S27.
38. Rönnemaa T, Pulkkike K, Kaprio J. Serum soluble tumor necrosis factor α receptor-2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity. J Clin Endocrinol Metab 2000; 85: 2728-2732.
39. Wilson AG, Simons JA, McDoeell TL, McDevitt HO. Effects of polymorphism of the human tumor necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
40. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J. The TNF-α gene NCO I polymorphism influences the relationship among insulin resistance, present body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468-1471.
41. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P. Excessive fat accumulation is associated with the TNF-alpha -308 G/A promoter polymorphism in women but not in men. Diabetologia 2000; 43: 117-120.
42. Romeo S, Federica S, Capici F, Arca M, Berni A, Vecci E, Di Mario U, Baroni MG. The G-308A variant of the tumor necrosis factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med Genet 2001; 2: 10-16.
43. Koch M, Rett K, Volk A, Maerker E, Haist K, Weisser M, Retting A, Renn W, Haring HU. The tumor necrosis factor alpha -238 G→A and 308 G→A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type II diabetic patients. Diabetologia 2000; 43: 181-184.
44. Da Silva B, Gaspur SM, Achenbach YH, Schuh TS, Kotla TJ, Liu K, Lowe WL Jr. Lack of association between the G-308A polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome. J Invest Med 2000; 48: 236-244.
45. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumor necrosis factor alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41: 430-434.
46. Lee SC, Pu YB, Thomas GN, Lee ZS, Tomlinson B, Cockram CS, Critchley JC, Chan JC. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 2000; 49: 1021-1024.
47. Walston J, Seibert M, Yen CJ, Cheskin LJ, Andersen RF. Tumor necrosis factor-alpha-238 and 308 polymorphism do not associate with traits related to obesity and insulin resistance. Diabetes 1999; 48: 2096-2098.